Loading…

Kidney biopsy in AA amyloidosis: impact of histopathology on prognosis

In AA amyloidosis, while kidney biopsy is widely considered for diagnosis by clinicians, there is no evidence that the detailed investigation of renal histopathology can be utilized for the prognosis and clinical outcomes. In this study, we aimed to obtain whether histopathologic findings in kidney...

Full description

Saved in:
Bibliographic Details
Published in:Amyloid 2017-07, Vol.24 (3), p.176-182
Main Authors: Kendi Celebi, Zeynep, Kiremitci, Saba, Ozturk, Bengi, Akturk, Serkan, Erdogmus, Siyar, Duman, Neval, Ates, Kenan, Erturk, Sehsuvar, Nergizoglu, Gokhan, Kutlay, Sim, Sengul, Sule, Ensari, Arzu, Keven, Kenan
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c366t-3d3e5ff6f4496769dea588411d400299ebeb143af2c350391437b656af7a1eb43
cites cdi_FETCH-LOGICAL-c366t-3d3e5ff6f4496769dea588411d400299ebeb143af2c350391437b656af7a1eb43
container_end_page 182
container_issue 3
container_start_page 176
container_title Amyloid
container_volume 24
creator Kendi Celebi, Zeynep
Kiremitci, Saba
Ozturk, Bengi
Akturk, Serkan
Erdogmus, Siyar
Duman, Neval
Ates, Kenan
Erturk, Sehsuvar
Nergizoglu, Gokhan
Kutlay, Sim
Sengul, Sule
Ensari, Arzu
Keven, Kenan
description In AA amyloidosis, while kidney biopsy is widely considered for diagnosis by clinicians, there is no evidence that the detailed investigation of renal histopathology can be utilized for the prognosis and clinical outcomes. In this study, we aimed to obtain whether histopathologic findings in kidney biopsy of AA amyloidosis might have prognostic and clinical value. This is a retrospective cohort study that included 38 patients who were diagnosed with AA amyloidosis by kidney biopsy between 2005 and 2013.The kidney biopsy specimens of patients were evaluated and graded for several characteristics of histopathological lesions and their relationship with renal outcomes. Segmental amyloid deposition in the kidney biopsy was seen in 29%, global amyloid deposition in 71, diffuse involvement of glomeruli in 84.2%, focal involvement in 7%, glomerular enlargement in 53%, tubular atrophy in 75% and interstitial fibrosis in 78% of patients. Histopathologically, glomerular enlargement, interstitial fibrosis, tubular atrophy, interstitial inflammation and global amyloid deposition were significantly associated with lower estimated glomerular filtration rate (eGFR) (p = .02, p 
doi_str_mv 10.1080/13506129.2017.1350158
format article
fullrecord <record><control><sourceid>proquest_infor</sourceid><recordid>TN_cdi_proquest_miscellaneous_1917362430</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1917362430</sourcerecordid><originalsourceid>FETCH-LOGICAL-c366t-3d3e5ff6f4496769dea588411d400299ebeb143af2c350391437b656af7a1eb43</originalsourceid><addsrcrecordid>eNp9kMtOwzAQRS0EolD4BJCXbFL8imOzoqp4iUpsYG05id0aJXGwU6H8PY5aWLKaGeuM7-gAcIXRAiOBbjHNEcdELgjCxWKacC6OwBkuGMuIwOI49ek1m6AZOI_xEyFCkRSnYEYEFzwn-Rl4fHV1Z0ZYOt_HEboOLpdQt2PjXe2ji3fQtb2uBugt3Lo4-F4PW9_4zQh9B_vgN92EXYATq5toLg91Dj4eH95Xz9n67elltVxnFeV8yGhNTW4tt4xJXnBZG50LwTCuWTpOSlOaEjOqLanS6VSmvih5zrUtNDYlo3Nws_83JX_tTBxU62JlmkZ3xu-iwhIXlBNGUULzPVoFH2MwVvXBtTqMCiM1KVS_CtWkUB0Upr3rQ8SubE39t_XrLAH3e8B11odWf_vQ1GrQyVmwQXeVi4r-n_EDeNZ_WA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1917362430</pqid></control><display><type>article</type><title>Kidney biopsy in AA amyloidosis: impact of histopathology on prognosis</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>Kendi Celebi, Zeynep ; Kiremitci, Saba ; Ozturk, Bengi ; Akturk, Serkan ; Erdogmus, Siyar ; Duman, Neval ; Ates, Kenan ; Erturk, Sehsuvar ; Nergizoglu, Gokhan ; Kutlay, Sim ; Sengul, Sule ; Ensari, Arzu ; Keven, Kenan</creator><creatorcontrib>Kendi Celebi, Zeynep ; Kiremitci, Saba ; Ozturk, Bengi ; Akturk, Serkan ; Erdogmus, Siyar ; Duman, Neval ; Ates, Kenan ; Erturk, Sehsuvar ; Nergizoglu, Gokhan ; Kutlay, Sim ; Sengul, Sule ; Ensari, Arzu ; Keven, Kenan</creatorcontrib><description>In AA amyloidosis, while kidney biopsy is widely considered for diagnosis by clinicians, there is no evidence that the detailed investigation of renal histopathology can be utilized for the prognosis and clinical outcomes. In this study, we aimed to obtain whether histopathologic findings in kidney biopsy of AA amyloidosis might have prognostic and clinical value. This is a retrospective cohort study that included 38 patients who were diagnosed with AA amyloidosis by kidney biopsy between 2005 and 2013.The kidney biopsy specimens of patients were evaluated and graded for several characteristics of histopathological lesions and their relationship with renal outcomes. Segmental amyloid deposition in the kidney biopsy was seen in 29%, global amyloid deposition in 71, diffuse involvement of glomeruli in 84.2%, focal involvement in 7%, glomerular enlargement in 53%, tubular atrophy in 75% and interstitial fibrosis in 78% of patients. Histopathologically, glomerular enlargement, interstitial fibrosis, tubular atrophy, interstitial inflammation and global amyloid deposition were significantly associated with lower estimated glomerular filtration rate (eGFR) (p = .02, p &lt; .001, p = .001, p = .009, p = .002, respectively) in univariate analysis. In multivariate analysis, tubular atrophy was the only predictor of eGFR (p = .019 B = −20.573). In the follow-up at an average of 27 months, 18 patients developed end-stage renal disease (ESRD). Among them, global amyloid deposition was the only risk factor for the development of ESRD (p = .01, OR = 18.750, %95 CI= 2.021-173.942). This is the first study showing that the histopathological findings in kidney biopsy of AA amyloidosis might have a prognostic and clinical value for renal outcomes.</description><identifier>ISSN: 1350-6129</identifier><identifier>EISSN: 1744-2818</identifier><identifier>DOI: 10.1080/13506129.2017.1350158</identifier><identifier>PMID: 28686525</identifier><language>eng</language><publisher>England: Taylor &amp; Francis</publisher><subject>AA amyloidosis ; Adult ; Aged ; Amyloid - metabolism ; amyloid deposition pattern ; Amyloidosis - diagnosis ; Amyloidosis - metabolism ; Amyloidosis - pathology ; Biopsy ; end-stage renal disease ; Female ; Glomerular Filtration Rate ; Humans ; Kidney Glomerulus - metabolism ; Kidney Glomerulus - pathology ; Male ; Middle Aged ; Prognosis ; renal pathology ; Retrospective Studies</subject><ispartof>Amyloid, 2017-07, Vol.24 (3), p.176-182</ispartof><rights>2017 Informa UK Limited, trading as Taylor &amp; Francis Group 2017</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c366t-3d3e5ff6f4496769dea588411d400299ebeb143af2c350391437b656af7a1eb43</citedby><cites>FETCH-LOGICAL-c366t-3d3e5ff6f4496769dea588411d400299ebeb143af2c350391437b656af7a1eb43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28686525$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kendi Celebi, Zeynep</creatorcontrib><creatorcontrib>Kiremitci, Saba</creatorcontrib><creatorcontrib>Ozturk, Bengi</creatorcontrib><creatorcontrib>Akturk, Serkan</creatorcontrib><creatorcontrib>Erdogmus, Siyar</creatorcontrib><creatorcontrib>Duman, Neval</creatorcontrib><creatorcontrib>Ates, Kenan</creatorcontrib><creatorcontrib>Erturk, Sehsuvar</creatorcontrib><creatorcontrib>Nergizoglu, Gokhan</creatorcontrib><creatorcontrib>Kutlay, Sim</creatorcontrib><creatorcontrib>Sengul, Sule</creatorcontrib><creatorcontrib>Ensari, Arzu</creatorcontrib><creatorcontrib>Keven, Kenan</creatorcontrib><title>Kidney biopsy in AA amyloidosis: impact of histopathology on prognosis</title><title>Amyloid</title><addtitle>Amyloid</addtitle><description>In AA amyloidosis, while kidney biopsy is widely considered for diagnosis by clinicians, there is no evidence that the detailed investigation of renal histopathology can be utilized for the prognosis and clinical outcomes. In this study, we aimed to obtain whether histopathologic findings in kidney biopsy of AA amyloidosis might have prognostic and clinical value. This is a retrospective cohort study that included 38 patients who were diagnosed with AA amyloidosis by kidney biopsy between 2005 and 2013.The kidney biopsy specimens of patients were evaluated and graded for several characteristics of histopathological lesions and their relationship with renal outcomes. Segmental amyloid deposition in the kidney biopsy was seen in 29%, global amyloid deposition in 71, diffuse involvement of glomeruli in 84.2%, focal involvement in 7%, glomerular enlargement in 53%, tubular atrophy in 75% and interstitial fibrosis in 78% of patients. Histopathologically, glomerular enlargement, interstitial fibrosis, tubular atrophy, interstitial inflammation and global amyloid deposition were significantly associated with lower estimated glomerular filtration rate (eGFR) (p = .02, p &lt; .001, p = .001, p = .009, p = .002, respectively) in univariate analysis. In multivariate analysis, tubular atrophy was the only predictor of eGFR (p = .019 B = −20.573). In the follow-up at an average of 27 months, 18 patients developed end-stage renal disease (ESRD). Among them, global amyloid deposition was the only risk factor for the development of ESRD (p = .01, OR = 18.750, %95 CI= 2.021-173.942). This is the first study showing that the histopathological findings in kidney biopsy of AA amyloidosis might have a prognostic and clinical value for renal outcomes.</description><subject>AA amyloidosis</subject><subject>Adult</subject><subject>Aged</subject><subject>Amyloid - metabolism</subject><subject>amyloid deposition pattern</subject><subject>Amyloidosis - diagnosis</subject><subject>Amyloidosis - metabolism</subject><subject>Amyloidosis - pathology</subject><subject>Biopsy</subject><subject>end-stage renal disease</subject><subject>Female</subject><subject>Glomerular Filtration Rate</subject><subject>Humans</subject><subject>Kidney Glomerulus - metabolism</subject><subject>Kidney Glomerulus - pathology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Prognosis</subject><subject>renal pathology</subject><subject>Retrospective Studies</subject><issn>1350-6129</issn><issn>1744-2818</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9kMtOwzAQRS0EolD4BJCXbFL8imOzoqp4iUpsYG05id0aJXGwU6H8PY5aWLKaGeuM7-gAcIXRAiOBbjHNEcdELgjCxWKacC6OwBkuGMuIwOI49ek1m6AZOI_xEyFCkRSnYEYEFzwn-Rl4fHV1Z0ZYOt_HEboOLpdQt2PjXe2ji3fQtb2uBugt3Lo4-F4PW9_4zQh9B_vgN92EXYATq5toLg91Dj4eH95Xz9n67elltVxnFeV8yGhNTW4tt4xJXnBZG50LwTCuWTpOSlOaEjOqLanS6VSmvih5zrUtNDYlo3Nws_83JX_tTBxU62JlmkZ3xu-iwhIXlBNGUULzPVoFH2MwVvXBtTqMCiM1KVS_CtWkUB0Upr3rQ8SubE39t_XrLAH3e8B11odWf_vQ1GrQyVmwQXeVi4r-n_EDeNZ_WA</recordid><startdate>20170703</startdate><enddate>20170703</enddate><creator>Kendi Celebi, Zeynep</creator><creator>Kiremitci, Saba</creator><creator>Ozturk, Bengi</creator><creator>Akturk, Serkan</creator><creator>Erdogmus, Siyar</creator><creator>Duman, Neval</creator><creator>Ates, Kenan</creator><creator>Erturk, Sehsuvar</creator><creator>Nergizoglu, Gokhan</creator><creator>Kutlay, Sim</creator><creator>Sengul, Sule</creator><creator>Ensari, Arzu</creator><creator>Keven, Kenan</creator><general>Taylor &amp; Francis</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20170703</creationdate><title>Kidney biopsy in AA amyloidosis: impact of histopathology on prognosis</title><author>Kendi Celebi, Zeynep ; Kiremitci, Saba ; Ozturk, Bengi ; Akturk, Serkan ; Erdogmus, Siyar ; Duman, Neval ; Ates, Kenan ; Erturk, Sehsuvar ; Nergizoglu, Gokhan ; Kutlay, Sim ; Sengul, Sule ; Ensari, Arzu ; Keven, Kenan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c366t-3d3e5ff6f4496769dea588411d400299ebeb143af2c350391437b656af7a1eb43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>AA amyloidosis</topic><topic>Adult</topic><topic>Aged</topic><topic>Amyloid - metabolism</topic><topic>amyloid deposition pattern</topic><topic>Amyloidosis - diagnosis</topic><topic>Amyloidosis - metabolism</topic><topic>Amyloidosis - pathology</topic><topic>Biopsy</topic><topic>end-stage renal disease</topic><topic>Female</topic><topic>Glomerular Filtration Rate</topic><topic>Humans</topic><topic>Kidney Glomerulus - metabolism</topic><topic>Kidney Glomerulus - pathology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Prognosis</topic><topic>renal pathology</topic><topic>Retrospective Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kendi Celebi, Zeynep</creatorcontrib><creatorcontrib>Kiremitci, Saba</creatorcontrib><creatorcontrib>Ozturk, Bengi</creatorcontrib><creatorcontrib>Akturk, Serkan</creatorcontrib><creatorcontrib>Erdogmus, Siyar</creatorcontrib><creatorcontrib>Duman, Neval</creatorcontrib><creatorcontrib>Ates, Kenan</creatorcontrib><creatorcontrib>Erturk, Sehsuvar</creatorcontrib><creatorcontrib>Nergizoglu, Gokhan</creatorcontrib><creatorcontrib>Kutlay, Sim</creatorcontrib><creatorcontrib>Sengul, Sule</creatorcontrib><creatorcontrib>Ensari, Arzu</creatorcontrib><creatorcontrib>Keven, Kenan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Amyloid</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kendi Celebi, Zeynep</au><au>Kiremitci, Saba</au><au>Ozturk, Bengi</au><au>Akturk, Serkan</au><au>Erdogmus, Siyar</au><au>Duman, Neval</au><au>Ates, Kenan</au><au>Erturk, Sehsuvar</au><au>Nergizoglu, Gokhan</au><au>Kutlay, Sim</au><au>Sengul, Sule</au><au>Ensari, Arzu</au><au>Keven, Kenan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Kidney biopsy in AA amyloidosis: impact of histopathology on prognosis</atitle><jtitle>Amyloid</jtitle><addtitle>Amyloid</addtitle><date>2017-07-03</date><risdate>2017</risdate><volume>24</volume><issue>3</issue><spage>176</spage><epage>182</epage><pages>176-182</pages><issn>1350-6129</issn><eissn>1744-2818</eissn><abstract>In AA amyloidosis, while kidney biopsy is widely considered for diagnosis by clinicians, there is no evidence that the detailed investigation of renal histopathology can be utilized for the prognosis and clinical outcomes. In this study, we aimed to obtain whether histopathologic findings in kidney biopsy of AA amyloidosis might have prognostic and clinical value. This is a retrospective cohort study that included 38 patients who were diagnosed with AA amyloidosis by kidney biopsy between 2005 and 2013.The kidney biopsy specimens of patients were evaluated and graded for several characteristics of histopathological lesions and their relationship with renal outcomes. Segmental amyloid deposition in the kidney biopsy was seen in 29%, global amyloid deposition in 71, diffuse involvement of glomeruli in 84.2%, focal involvement in 7%, glomerular enlargement in 53%, tubular atrophy in 75% and interstitial fibrosis in 78% of patients. Histopathologically, glomerular enlargement, interstitial fibrosis, tubular atrophy, interstitial inflammation and global amyloid deposition were significantly associated with lower estimated glomerular filtration rate (eGFR) (p = .02, p &lt; .001, p = .001, p = .009, p = .002, respectively) in univariate analysis. In multivariate analysis, tubular atrophy was the only predictor of eGFR (p = .019 B = −20.573). In the follow-up at an average of 27 months, 18 patients developed end-stage renal disease (ESRD). Among them, global amyloid deposition was the only risk factor for the development of ESRD (p = .01, OR = 18.750, %95 CI= 2.021-173.942). This is the first study showing that the histopathological findings in kidney biopsy of AA amyloidosis might have a prognostic and clinical value for renal outcomes.</abstract><cop>England</cop><pub>Taylor &amp; Francis</pub><pmid>28686525</pmid><doi>10.1080/13506129.2017.1350158</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1350-6129
ispartof Amyloid, 2017-07, Vol.24 (3), p.176-182
issn 1350-6129
1744-2818
language eng
recordid cdi_proquest_miscellaneous_1917362430
source Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)
subjects AA amyloidosis
Adult
Aged
Amyloid - metabolism
amyloid deposition pattern
Amyloidosis - diagnosis
Amyloidosis - metabolism
Amyloidosis - pathology
Biopsy
end-stage renal disease
Female
Glomerular Filtration Rate
Humans
Kidney Glomerulus - metabolism
Kidney Glomerulus - pathology
Male
Middle Aged
Prognosis
renal pathology
Retrospective Studies
title Kidney biopsy in AA amyloidosis: impact of histopathology on prognosis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T03%3A26%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_infor&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Kidney%20biopsy%20in%20AA%20amyloidosis:%20impact%20of%20histopathology%20on%20prognosis&rft.jtitle=Amyloid&rft.au=Kendi%20Celebi,%20Zeynep&rft.date=2017-07-03&rft.volume=24&rft.issue=3&rft.spage=176&rft.epage=182&rft.pages=176-182&rft.issn=1350-6129&rft.eissn=1744-2818&rft_id=info:doi/10.1080/13506129.2017.1350158&rft_dat=%3Cproquest_infor%3E1917362430%3C/proquest_infor%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c366t-3d3e5ff6f4496769dea588411d400299ebeb143af2c350391437b656af7a1eb43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1917362430&rft_id=info:pmid/28686525&rfr_iscdi=true